Expression and regulation of the catecholamine-synthesizing enzymes phenylethanolamine N-methyltransferase (PNMTase; S-adenosyl-L-methionine:phenylethanolamine N-methyltransferase, EC 2.1.1.28) and tyrosine hydroxylase [TyrOHase; tyrosine 3-monooxygenase, L-tyrosine, tetrahydropteridine:oxygen oxidoreductase (3-hydroxylating), EC 1.14.16.2] and the coexisting neuropeptide tyrosine (NPY) were studied in rat and bovine adrenal medulla. By using both immunohistochemistry and in situ hybridization, PNMTase-and NPY-positive cells exhibited a close overlap in bovine medulla and were preferentially localized in the outer two-thirds of the medulla. Although TyrOHase and its mRNA were observed in virtually all medullary gland cells, TyrOHase mRNA levels were much higher in the PNMTase-and NPYpositive cells. After administration of the catecholaminedepleting drug reserpine to rats, a brief increase, followed by a dramatic decrease, in the level of PNMTase mRNA was observed in the adrenal medulla. In contrast, mRNA for both TyrOHase and NPY only exhibited an increase, whereby the TyrOHase mRNA peak preceded that of NPY mRNA. Different regulatory mechanisms may thus operate for these three compounds coexisting in the adrenal medulla.
The synthesis of catecholamines is catalyzed by four enzymes including tyrosine hydroxylase [TyrOHase; tyrosine 3-monooxygenase, L-tyrosine, tetrahydropteridine:oxygen oxidoreductase (3-hydroxylating), EC 1.14. 16 .2] and phenylethanolamine N-methyltransferase (PNMTase; S-adenosyl-L-methionine:phenylethanolamine N-methyltransferase, EC 2.1.1.28) (1). TyrOHase (2) converts L-tyrosine to 3,4-dihydroxyphenylalanine (dopa) and is the rate-limiting enzyme. PNMTase (3) is responsible for the formation of epinephrine from norepinephrine (4) . Recently the cDNAs for bovine PNMTase (5) and rat PNMTase (see ref. 6 ) have been cloned and, by using in situ hybridization, the localization of PNMTase mRNA has been studied in the adrenal gland and the brain (6) . Also TyrOHase mRNA has been studied with in situ hybridization (7) (8) (9) . Neuropeptide tyrosine (NPY) (10) coexists with epinephrine and norepinephrine in the rat adrenal medulla, and its expression as well as that of TyrOHase is known to be increased in stress and after injection of the catecholamine-depleting drug reserpine (for references, see ref. 11) .
In this study, we have attempted to elucidate the localization of mRNAs for PNMTase, TyrOHase, and NPY and their products in the bovine adrenal gland by using antisera and a variety of nucleotide probes. Furthermore, a quantitative in situ hybridization method has been used to determine in some detail the differential gene expression of the three mRNAs in the rat adrenal gland after treatment with the monoaminedepleting drug reserpine (12, 13) .
MATERIALS AND METHODS
Sixty male Sprague-Dawley rats (body weight of 150-200 g, pathogen-free; ALAB) and bovine adrenals (Forsoksslakten) were used. Reserpine (Serpasil; CIBA-Geigy) was given i.p. In addition, in the dose-response experiment, the drug was given i.v. in the lingual vein under short ether anesthesia (for doses, see Results). The rats were decapitated after various time intervals (see Results). The adrenals were dissected out, frozen, sectioned at 14 ,um in a cryostat (Dittes), and thawed onto slides pretreated with poly(L-lysine) at 50 ,ug/ml (Sigma). The sections were air dried, immersed in 10% formalin for 30 min, rinsed, dehydrated in a graded series of ethanol, incubated for 5 min in chloroform, and air dried according to published procedures (14, 15) .
Preparation of Probes. Eight 48-mer oligonucleotides were synthesized on a DNA synthesizer (Applied Biosystems). The oligonucleotide probes were complementary to nucleotides 655-702 (bPNMTase-1), 22-69 (bPNMTase-2), and 607-654 (bPNMTase-3) of bovine PNMTase mRNA (5); nucleotides -37 to 11 (rPNMTase) of rat PNMTase mRNA (see ref. 6); nucleotides 1441-1488 (rTyrOHase) of rat TyrOHase mRNA (16) , nucleotides 1-48 (hTyrOHase) of human TyrOHase mRNA (17) , nucleotides 280-327 (hCCK) of human cholecystokinin (CCK) mRNA (18) , and nucleotides 171-218 (hNPY) of human NPY mRNA (19) . All oligonucleotides were labeled with [a-35S]dATP (New England Nuclear) at the 3' end as described (6, 20) .
Hybridization Procedure. In brief, the slides were incubated at 42°C for 18 hr with 1 x 106 cpm of the labeled probe (2-7 x 108 cpm/,ug) in a solution containing 50% formamide (Baker), 4x SSC (lx SSC = 0.15 M sodium chloride/0.015 M sodium citrate, pH 7), lx Denhardt's solution (0.02% polyvinylpyrrolidone/0.02% Ficoll/0.02% bovine serum albumin), 1% sarcosyl (N-lauroylsarcosine) (Sigma), 0.02 M sodium phosphate at pH 7, 10% dextran sulfate at pH 7.0 (Pharmacia), yeast tRNA at 500 ug/ml (Sigma), salmon sperm DNA at 250 ug/ml (Sigma), and 60 mM dithiothreitol (LKB). After hybridization (15-24 hr) , the sections were rinsed in 1 x SSC at 55°C for 60 min with four changes of SSC, dehydrated, and covered with Hyperfilm-j'max x-ray film Abbreviations: CCK, cholecystokinin; -LI, -like immunoreactivity; NPY, neuropeptide tyrosine; PNMTase, phenylethanolamine Nmethyltransferase; TyrOHase, tyrosine hydroxylase.
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Immunohistochemistry was performed according to Coons (21) with NPY (1:400), TyrOHase (1:400 or 1:800), or PNMTase antisera (1:500 or 1:1000) and fluorescein isothiocyanateconjugated secondary antibodies (1:40, as described in ref. 15 ). For controls, see ref. 15 .
RNA Blot Analysis. Poly(A)-RNA was prepared (22), purified (23), separated on a formaldehyde-containing 1% agarose gel, blotted to a nitrocellulose filter, and hybridized with a 32P-labeled oligonucleotide probe in 50% formamide/4 x SSC/10% dextran sulfate as previously described (24) . The oligonucleotide probe was labeled at the 3' end with [a-32P]-dATP (New England Nuclear) and terminal deoxynucleotidyltransferase (International Biotechnologies). Filters were washed at high stringency [0.1 x SSC/0.1% sodium dodecyl sulfate (SDS) at 540C].
RESULTS
In the bovine adrenal, the PNMTase-immunoreactive cells were localized preferentially in the outer two-thirds of the medulla (Fig. la) . The NPY-positive cells (Fig. ic) showed a marked overlap but were, in general, somewhat less abundant (e.g., around major blood vessels; compare Fig. 1 a and  c) . TyrOHase-like immunoreactivity (LI) (Fig. lb) extended throughout the medulla, which gave rise to a central TyrOHase-positive, PNMTase-negative cell population that did not contain NPY-LI (Fig. lb) and may be noradrenergic in nature. None of the staining patterns described above were observed after incubation with control sera.
Hybridization of sections of both rat and bovine adrenal glands with several different PNMTase probes as well as TyrOHase and NPY probes (Fig. 2 a-f) showed different patterns. Thus, of three probes complementary to different parts of the bovine PNMTase mRNA sequence (bPNMTase-1, -2, and -3), two probes (bPNMTase-1 and bPNMTase-2) showed hybridization only to the bovine tissue ( Fig. 2 a and  b) , whereas one (bPNMTase-3) gave rise to strong hybridization in both bovine and rat adrenal medulla (Figs. ld and 2c). In the bovine gland, all three probes preferentially labeled the outer two-thirds of the medulla as well as cells around blood vessels (Fig. 2 a-c) , in agreement with the immunohistochemical results. The bPNMTase-3 probe was complementary to mRNA coding for the presumed catalytic site of the enzyme and with close sequence similarity to the human sequence (25) . The rPNMTase probe, which had little sequence similarity with the bovine sequence, showed strong hybridization in rat tissue but no hybridization in bovine adrenal gland (Fig. 2d) . In Figs. le and 2e, a human TyrOHase probe with close sequence similarity to rat TyrOHase was used, which showed labeling of all bovine adrenal medullary gland cells. However, a markedly stronger expression of TyrOHase mRNA was seen in the outer two-thirds of the medulla, which correlates well with PNMTaseexpressing cells (compare Fig. 2 e and a-c) . The human NPY probe labeled mainly the outer part of the adrenal medulla (Figs. ifand 2f; i.e., overlapping with the peripheral PNMTase cells). The control probe, complementary to human CCK mRNA and with similar G + C content, length, and specific activity, did not give rise to any specific labeling in rat or (Fig. 2g) but hybridized strongly to many brain areas (data not shown).
One of the probes, bPNMTase-1, was used in a Northern blot experiment, which resulted in a strong hybridization with poly(A)-RNAs from bovine adrenal with a transcript of -1 kilobase (Fig. 2h) . This is in agreement with the reported size of bovine PNMTase mRNA (5) .
After a single injection of reserpine (10 mg/kg, i.p.), a strong but transient increase, followed by a dramatic decrease, in PNMTase mRNA expression was observed in the rat adrenal medulla (Fig. 3 a and d) , whereas a marked increase in TyrOHase (Fig. 3 b and e) and NPY ( Fig. 3 c and f) mRNA expression was seen. A rapid increase of TyrOHase mRNA was observed; there was already a high level at 3 hr (Fig. 3e) , whereas NPY mRNA increased more slowly with a clear elevation at 18 hr (Fig. 3f) . By using quantitative autoradiography (Figs. 4 and 5) , it was shown that the PNMTase mRNA increase was 4-fold (Bq/mg of tissue) at 6 hr, whereas the decrease after 1 day represented an -90% reduction in mRNA compared with control levels. TyrOHase mRNA increased to 240% of control levels after 1 day. NPY mRNA, however, peaked at 2 days, and reached =600% of control levels. Nine days after the single injection of reserpine, all three mRNA levels were back to control values.
The effects of different reserpine doses (i.v. injections) are shown in Fig. 6 . PNMTase mRNA showed a dose-dependent decrease (Fig. 6a) with a small reduction induced by ether anesthesia alone (Fig. 6a ). Both TyrOHase (Fig. 6b) and NPY (Fig. 6c) mRNAs showed a dose-dependent increase with the exception of TyrOHase after the highest dose of reserpine (only seen in the i.v. experiments). Anesthesia did not influence TyrOHase and NPY mRNA (Fig. 6 b and c) .
DISCUSSION
By using both immunohistochemistry and in situ hybridization, the expression of PNMTase was localized to the outer two-thirds of the bovine adrenal medulla, in contrast to the rat adrenal gland, where the PNMTase-cells are more evenly distributed throughout the medulla (26, 27) . NPY was confined only to PNMTase-positive cells in the bovine adrenal medulla, whereas in the rat both epinephrine and norepinephrine cells contain this peptide (see ref. 15 ). The fact that PNMTase expression is present only in the outer two-thirds of the medulla and around vessels is compatible with the view that there is a permissive effect on enzyme synthesis of steroids from the adrenal cortex (28) . It is interesting that, although TyrOHase mRNA and TyrOHase-LI are present in virtually all medullary gland cells, the TyrOHase mRNA levels were considerably higher in the outer two-thirds (i.e., overlapping with PNMTase), which indicates that conversion of tyrosine to L-dopa is higher in this part of the medulla. It has previously been shown that the TyrOHase gene expression is increased with glucocorticoid treatment in pheochro- way. Thus, whereas TyrOHase and NPY mRNA showed a lands at different times long lasting increase and returned to base-line levels at 4 days Se dose of reserpine (10 or later, PNMTase mRNA exhibited a transient increase (up )r PNMTase (a and d), 400% at 6 hr), followed by a dramatic decrease (a decrease of A expression. Note the 90% from control levels at 24 hr). The increase in TyrOHase on (a) and the increase mRNA levels after a high dose of reserpine may at least in n after 1 day. Note that part reflect a neurally mediated response in the chromaffin 24 hr (a) was preceded cells to increase their catecholamine synthesis after depletion '. (Bars = 1 mm.) The of catecholamines (33, 34) . * With respect to NPY-LI, an initial decrease followed by a PyrOHase activity is marked increase has been described after reserpine treatment high doses of adre- (11, 35) , whereas, as shown here, NPY mRNA increased with increase TyrOHase a peak on the second day after reserpine (i.e., 1 day later than nedulla (30-32)T for TyrOHase mRNA). Insulin treatment has also been nedullan (30) (31) (32) .*shown to increase NPY mRNA levels, which was completely ase changed mRNA prevented by bilateral transection of the splanchnic nerve base in a differential (36) . Thus increased impulse activity in the splanchnic nerve may be responsible for the effects of insulin on NPY mRNA TyrO~ase levels (34) , and a similar mechanism may operate in the TyrOHase present experiments with reserpine. The different time PNMTase course for the increase in NPY mRNA and TyrOHase mRNA NPY after a high dose of reserpine may indicate a differential regulation for the peptide and enzyme. Also, the initial increase in PNMTase mRNA may be related to increased impulse activity in the splanchnic nerves. In contrast, the marked decrease in PNMTase mRNA seen 24-72 hr after reserpine may represent effects of this drug on the pituitary/central nervous system. Thus, it was shown early that reserpine depletes ACTH content (37) (38) (39) . Furthermore, it has been demonstrated that vasopressinneurophysin-LI (40) and corticotropin-releasing factor-LI (41, 42) in the median eminence are markedly depleted after a high dose of reserpine. It is therefore possible that the decrease in PNMTase mRNA in the adrenal medulla is a consequence ofinsufficient steroid secretion due to depletion I 8 9 lo of corticotropin-releasing factor and ACTH at the brain and 7 8 9 10 pituitary level, respectively. This further supports the pioneering work by Wurtman and Axelrod (28) demonstrating ctions shown in Fig. 3 the importance of steroids for PNMTase synthesis. 
